Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women - 08/09/20
Abstract |
Background |
Taller individuals are at higher risk of melanoma.
Objective |
To prospectively investigate the association of height with nevus count and melanoma and estimate the proportion of height-melanoma association explained by nevus count among white participants from the Nurses' Health Study (NHS) and Nurses' Health Study 2 (NHS2).
Methods |
We used Cox proportional hazards regression and multinomial logistic regression for data analyses, with adjustment of potential confounders in the multivariate model.
Results |
We included 82,468 and 106,069 women from NHS and NHS2, respectively. The hazard ratio was 1.21 (95% confidence interval [CI] 1.12-1.31) for the association between every 10-cm increase in height and melanoma. Compared with women with no nevi, the odds ratios (95% CIs) associated with a 10-cm increase in height were 1.35 (95% CI 1.23-1.48) in the NHS and 1.12 (95% CI 1.09-1.15) in the NHS2 for women with greater than or equal to 10 moles. The proportion of excess melanoma risk associated with each 10-cm increase in height explained by nevus count was 8.03% in the NHS and 10.22% in the NHS2.
Limitation |
Self-reported height and nevus count. Mole counts were limited to 1 arm or both legs.
Conclusion |
Nevus count is an important explanatory factor for the excess risk of melanoma among taller white women.
Le texte complet de cet article est disponible en PDF.Key words : cutaneous melanoma, height, nevus count, prospective cohorts
Abbreviations used : CI, HR, NHS, NHS2, OR
Plan
| Funding sources: Supported by National Institutes of Health grants P01 CA87969, UM1 CA186107, and U01 CA176726. |
|
| Conflicts of interest: None disclosed. |
|
| The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
| IRB approval status: The study protocol was approved by the institutional review boards of the Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required. |
Vol 83 - N° 4
P. 1049-1056 - octobre 2020 Retour au numéro
Article précédent
- The infection rate of intralesional triamcinolone and the safety of compounding in dermatology for intradermal and subcutaneous injection: A retrospective medical record review
- Chelsea A. Luther, James L. Griffith, Elena Kurland, Reem Al Shabeeb, Misty Eleryan, Kelley Redbord, David M. Ozog
- Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers
- Oriol Yélamos, Elena Manubens, Manu Jain, Marion Chavez-Bourgeois, Sri V. Pulijal, Stephen W. Dusza, Michael A. Marchetti, Alicia Barreiro, Maria L. Marino, Josep Malvehy, Miguel A. Cordova, Anthony M. Rossi, Milind Rajadhyaksha, Allan C. Halpern, Susana Puig, Ashfaq A. Marghoob, Cristina Carrera
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?